While a medical student at Northwestern University, Wanke took night classes at the Northwestern’s Kellogg School of Management. It was there that he met Dr. Dan McCarthy, and later Dr. David Mahvi, who introduced him to the excision then RFA or “eRFA” pilot work being done by Dr. Suzanne Klimberg, a famous breast surgeon. The group took the idea of ablation and conceived of the Innoblative device, which is specifically designed to use radiofrequency waves to kill potentially cancerous tissue left after surgery.
“We interviewed dozens of surgeons and took all of their feedback into account to create a device that is human factors-engineered for this kind of procedure,” explains Wanke of developing the product. “It is interdisciplinary collaboration at it’s best.”
Wanke took a leave of absence from medical school to attend Northwestern’s Kellogg School of Management full time to learn more about business while they launched Innoblative. Now he’s a full time “Innoblator” and still sees patients every other week to stay sharp.
Send this to a friend